Crossmark

Applicability and validation of different prognostic scores in allogeneic hematopoietic cell transplant (HCT) in the post-transplant cyclophosphamide era

Crossref DOI link: https://doi.org/10.1016/j.htct.2023.07.008

Published Print: 2024-12

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Salas, María Queralt https://orcid.org/0000-0003-4567-3682
Rodríguez-Lobato, Luis Gerardo https://orcid.org/0000-0001-5694-0921
Charry, Paola https://orcid.org/0000-0002-4777-9643
Suárez-Lledó, Maria

Pedraza, Alexandra

Solano, María Teresa

Arcarons, Jordi

Cid, Joan https://orcid.org/0000-0001-5445-4508
Lozano, Miquel

Rosiñol, Laura https://orcid.org/0000-0002-2534-9239
Esteve, Jordi

Carreras, Enric

Fernández-Avilés, Francesc https://orcid.org/0000-0002-3733-590X
Martínez, Carmen

Rovira, Montserrat
License Information

Text and Data Mining valid from 2024-12-01

Text and Data Mining valid from 2024-12-01

Version of Record valid from 2023-08-23
More Information

This article is maintained by: Elsevier

Article Title: Applicability and validation of different prognostic scores in allogeneic hematopoietic cell transplant (HCT) in the post-transplant cyclophosphamide era

Journal Title: Hematology, Transfusion and Cell Therapy

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.htct.2023.07.008

Content Type: article

Copyright: © 2023 Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier España, S.L.U.

Document is current

Any future updates will be listed below